共 181 条
[1]
Hallet J(2015)Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes Cancer 121 589-597
[2]
Law CH(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[3]
Cukier M(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 3063-3072
[4]
Saskin R(2015)Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis J Gastroenterol 50 58-64
[5]
Liu N(2013)Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib Ther Adv Gastroenterol 6 396-411
[6]
Singh S(2011)Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 501-513
[7]
Siegel RL(2011)Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 514-523
[8]
Miller KD(2012)Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial Jpn J Clin Oncol 42 903-911
[9]
Jemal A(2013)Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor Invest New Drugs 31 1265-1274
[10]
Yao JC(2015)Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan J Gastroenterol 50 769-775